AKI Recognition and Management Audit

Free projects are complete and ready to use. Paid projects can also be adapted to your local requirements. This project uses a fixed Lazomis clinical configuration of 24 audit criteria across recognition and staging, investigation and monitoring, fluid status and urine output, cause assessment, medicines safety and renal dosing, escalation and specialist advice, and discharge communication and follow-up. Data collection, dashboards, findings, improvement planning, re-audit and every output are included at no cost.

• Foundation Doctors and Internal Medicine Trainees
• Acute Medicine and ward teams
• AKI nurses, renal teams and pharmacists
• Governance and Audit leads

• Measure recognition, staging and investigation of AKI
• Assess fluid status, urine output and monitoring documentation
• Review medicines safety, renal dosing, escalation and specialist advice
• Generate governance-ready evidence and post-AKI follow-up assurance

• Anonymised case identifier
• Care setting, AKI context and AKI stage
• Recognition, cause assessment and monitoring documentation
• Medicines review, escalation, discharge communication and follow-up

• Live dashboard
• Audit report (Word)
• Executive summary (Word)
• Excel workbook
• PowerPoint presentation
• Conference poster
• ARCP evidence summary

• Designed to use anonymised or pseudonymised audit identifiers.
• This tool supports, but does not replace, clinical judgement.
• Local policy, formulary and specialist advice should be followed.
• Organisations remain responsible for local governance arrangements.
• This audit tool supports AKI recognition and management documentation review and quality improvement. It does not replace clinical judgement, local AKI policy, fluid or medicines guidance, renal dosing advice, nephrology advice or emergency escalation pathways.
• Audit data alone cannot support conclusions about preventability, causality, avoidable harm, policy breach or professional misconduct.
• AKI staging thresholds, monitoring intervals, referral criteria and follow-up arrangements are set by national guidance and local policy and are not defined by this tool.
• Use anonymous case identifiers only — never patient-identifiable information.

Supporting guidance from the Lazomis QI Resource Library. Authoritative clinical standards referenced by this project remain separate.

• Clinical GovernanceClinical Governance Explained: A Framework for Quality and Safety in the NHSThis article defines clinical governance, outlines its key pillars, and explains why a robust framework is crucial for maintaining and improving patient safety and quality of care within the NHS.
• Clinical GovernanceTurning Governance Data into Clinical ImprovementThis guide outlines how NHS teams can transform routine clinical governance data into actionable insights, driving measurable improvements in patient care, safety, and efficiency. It covers practical steps from data collection to implementation and review.
• Clinical GovernanceEffective Clinical Governance Meetings: Driving Improvement, Not Just ReportingThis guide helps NHS teams redefine their clinical governance meetings, moving beyond mere reporting to foster proactive discussion, shared learning, and tangible improvement actions for patient safety and quality of care.
• Patient SafetyMedicines Safety: A Systems Approach to Reducing HarmThis guide moves beyond individual error, explaining how a systems-based approach can fundamentally improve medicines safety across the NHS and reduce patient harm by addressing underlying contributing factors.